On January 31st, 2013 recruitment started in the DEEP-1 study (multi-centre, oral single dose experimental and modelling study to evaluate the pharmacokinetics of deferiprone in patients aged from 1 month to less than 6 years of age affected by transfusion-dependent haemoglobinopathies) and the first patient was enrolled at the Azienda Ospedaliera “A. Cardarelli” in Naples.
The DEEP project has received research funding from the European Union under the 7th Framework Programme
